IDEXX Laboratories/ US45168D1046 /
| 6/28/2022 10:00:00 PM | Chg. -9.8200 | Volume | Bid3:29:29 PM | Ask3:29:48 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 349.2100USD | -2.74% | 431,049 Turnover: 76.1 mill. |
337.0100Bid Size: 200 | 350.9800Ask Size: 500 | 29.34 bill.USD | 0.00% | 39.96 |
Assets
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 379.1000 | 437.3000 | 533.8000 | 555.2000 | 587.7000 | ||||||
| Intangible Assets | 43.8000 | 41.8000 | 58.5000 | 52.5000 | 99 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 164.3000 | 173.3000 | 195 | 209.9000 | 269 | ||||||
| Accounts Receivable | 234.6000 | 248.9000 | 269.3000 | 331.4000 | 368.3000 | ||||||
| Cash and Cash Equivalents | 187.7000 | 123.8000 | 90.3000 | 383.9000 | 144.5000 | ||||||
| Current Assets | 972 | 654.2000 | 679.6000 | 1,062.7000 | 955.7000 | ||||||
| Total Assets | 1,713.4000 | 1,537.3000 | 1,832.5000 | 2,294.6000 | 2,437.2000 | ||||||
Liabilities
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 67 | 69.5000 | 72.2000 | 74.6000 | 116.1000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 655 | 398.9000 | 288.8000 | 0.0000 | 0.0000 | ||||||
| Provisions | 253.4000 | 260.7000 | 322.9000 | 415.6000 | 458.9000 | ||||||
| Liabilities | 1,767.3000 | 1,546.6000 | 1,654.7000 | 1,661.8000 | 1,747.2000 | ||||||
| Share Capital | 10.4280 | 10.5090 | 10.5710 | 10.6460 | 10.6880 | ||||||
| Total Equity | -53.8000 | -9.2000 | 177.8000 | 632.8000 | 690 | ||||||
| Minority Interests | .3000 | .3000 | .4000 | .7000 | 0.0000 | ||||||
| Total liabilities equity | 1,713.4000 | 1,537.3000 | 1,832.5000 | 2,294.6000 | 2,437.2000 | ||||||
Income Statement
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,969.1000 | 2,213.2000 | 2,406.9000 | 2,706.7000 | 3,215.4000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 413 | 491.3000 | 552.8000 | 694.5000 | 932 | ||||||
| Interest Income | -31.9000 | -33.6000 | -30.7000 | -32.5000 | -29.4000 | ||||||
| Income Before Taxes | 381.1000 | 457.7000 | 522.2000 | 662 | 902.7000 | ||||||
| Income Taxes | 117.8000 | 80.7000 | 94.4000 | 79.9000 | 157.8000 | ||||||
| Minority Interests Profit | -.1000 | -.0200 | -.0700 | -.4000 | 0.0000 | ||||||
| Net Income | 263.1000 | 377 | 427.7000 | 581.8000 | 744.8000 | ||||||
Per Share
Cash Flow
|
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 373.3000 | 400.1000 | 459.2000 | 648.1000 | 755.5000 | ||||||
| Cash Flow from Investing Activities | -138.7000 | 138.6000 | -205.5000 | -109.4000 | -293 | ||||||
| Cash Flow from Financing | -208 | -597.8000 | -286.4000 | -248.4000 | -697.4000 | ||||||
| Decrease / Increase in Cash | 32.8000 | -63.9000 | -33.5000 | 293.6000 | -239.5000 | ||||||
| Employees | 7,600 | 8,377 | 9,200 | 9,300 | 10,350 | ||||||